Home
overview

SMi Group’s Parallel Trade conference returns to London for its 12th year on 6th-7th Feb 2018
Over the years, the European Single market has allowed for pharmaceuticals to be imported and exported freely between member states without the permission of the manufacturers. However, with the arrival of Brexit and guidelines to immanently enforce the Falsified Medicines Directive (FMD) by 2019, the market for pharmaceutical parallel trade is changing.


Join us as we discuss the latest changes to regulation, their implementation and major court cases in intellectual property influencing distribution practices. We will also be exploring the safety of patients in relation to the surge in pharmaceutical E-commerce and ways in which currency fluctuations are likely to disrupt the flow of drugs to certain countries in the EU and beyond.
 

This event will discuss short term versus long term concerns of pharmaceutical manufacturers, regulators, parallel traders and patient associations 

Attend Europe’s only parallel trade conference
Hear from Merck and Shire as they debate the effect of parallel trade on pharmaceutical companies and access to medicines
Discuss how Brexit will impact pharmaceutical trade and market access in Europe
Gain insight into current anti- trust investigations from industry leaders and the consequences this could have on pharmaceutical parallel trade
Forecast of currency fluctuations across the single market and the affect this might have on drug shortages, prices and
patient accessibility
Hear new case studies from parallel trade companies Lexano and MD Pharma in Europe

VPs, Directors, Heads, Chiefs, Principals and Managers of:
• Parallel Trade/ Import/ Export
• Distribution
• Supply Chain Management/ Planning
• General Counsel / Legal
• Market Access
• Business Planning
• Pricing
• Finance
• Procurement/ Sales
• Regulatory/ Public Affairs


From pharmaceutical and biotechnology companies, drug manufacturers, pharmaceutical wholesalers, pharmacies, pharmaceutical importers and exporters, parallel traders, medical device, regulatory bodies and academia
 

Abbvie; ABPI; Aeterna Zentaris GmbH; Amgen ; APM Health Europe; Apotek; Arnold & Porter Kaye Scholer; Astellas Pharma Ltd; AstraZeneca; AstraZeneca Czech Republic; Bristol Myers Squibb; Cartermatic Trading Enterprise; Chiesi Farmaceutici SpA; Clinical Insights; Clinigen Group; Daiichi Sankyo Europe GmbH; Diamond BioPharm Ltd; Durbin Plc; Ema; Europe Economics; European Alliance for Access to Safe Medicines; European Association of Euro-Pharmaceutical Companies ; Ferring Pharmaceuticals; Ferring Pharmaceuticals Ltd; Gilead Sciences Ltd; Grunenthal GmbH; H.Lundbeck; Idea Medica Limited; IMS Health GmbH & Co. OHG; Janssen Pharmaceutica NV; Johnson and Johnson ; Kantar Health; Kantar Health GmbH; LEO Pharma; medac GmbH; MHRA; MPA Business Services Ltd; Napp Laboratories; Novartis AG; Novartis Pharmaceuticals UK Ltd; NOVARTIS TURKEY; Novo Nordisk Pharma AG; Nupharm Laboratories Ltd; Omnia Läkemedel; Pharm-in, spol . S.R.O; Phoenix Healthcare Distribution Limited; QuintilesIMS; Ratiopharm GmbH; Research Health; Shire Pharmaceuticals Limited; Smith & Nephew; Sobi; Sunovion Pharmaceuticals Europe Ltd.; Swedish Orphan Biovitrum AB (publ); Takeda Pharmaceuticals International AG; Teva UK Limited; Tioluxe Pte Ltd; Vertex Pharmaceuticals (Europe) Ltd; Vifor Pharma Ltd

Conference programme

8:30 Registration & Coffee

9:00 Chair's Opening Remarks

Eric  Noehrenberg

Eric Noehrenberg, President, Noehrenberg International Policy Consulting

9:10 Evolution of parallel trade in Pharma 4.0

Fabrizio Gianfrate

Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

• Impact and response of parallel trade on tomorrow’s pharma
• Future scenarios of Parallel trade for manufacturers, wholesalers and pharmacists
• The effect of Brexit on PT
• Possible win-win solutions
 

9:50 Parallel trade and antitrust - an overview of recent developments in the EU

Werner Berg

Werner Berg, Partner, Baker & Mckenzie

• Parallel trade – key issues and EU law
• Enforcement overview regarding pharma distribution
• Practical options for pharmaceutical companies

 

10:30 Morning Coffee

11:00 The impact of parallel trade on pharmaceutical companies

Doina Ionescu

Doina Ionescu, Managing Director, Merck Rumania

• Factors and drivers of parallel trade in Europe
• The economics of parallel trade
• Trends in pharmaceutical parallel trade

11:40 Does it always have to be a fight? Can parallel distribution and industry work together?

Antonio Mendonca Alves

Antonio Mendonca Alves, CEO, MD Pharma SA

• Product safety: Product double checking and the promise
of the FMD
• Patient access: How PD can be effective in bridging supply
chain disruptions
• Re-thinking revenue: Can parallel distribution be a useful
price segmentation tool?
 

12:20 Networking Lunch

13:50 Intellectual Property and regulatory law: Recent developments

Christopher Stothers

Christopher Stothers, Partner, Arnold and Porter Kaye Scholer LLP

• IP developments in the EU and USA
• Regulatory issues
• Brexit focus: news and expectations

14:10 Afternoon Tea

14:30 Pharmaceutical pricing practices, competition law and parallel trade: What do recent antitrust abuses by pharmaceutical companies mean for parallel trade?

Iona McCall

Iona McCall, Managing Consultant, Europe Economics

• Overview of key recent cases in UK and EC
• Main issues
• Regulatory context in which these have occurred
• What are the implications of these cases for parallel trade
 

15:40 Economics of Pay for delay deals

Farasat Bokhari

Farasat Bokhari, Senior Lecturer in Economics, UEA, University of East Anglia

• What are Pay for delay deals?
• Why do they come about?
• How much do they cost the society?
• What can we do about it?

16:20 The evolving parallel trade environment in Europe

17:00 Chair’s Closing Remarks and Close of Day One

8:30 Registration & Coffee

9:00 Chair's Opening Remarks

Eric  Noehrenberg

Eric Noehrenberg, President, Noehrenberg International Policy Consulting

9:10 Medicine shortages in Ireland – causes, impact and mitigation

Darragh O'loughlin

Darragh O'loughlin, Secretary General, Irish Pharmacy Union

• Current Shortages – what medicines are affected and why?
• Mitigating the Impact – what are we doing and is it working?
• Potential Future Strategies – what works elsewhere and are export bans a solution?

9:50 Medicine quotas: What is the impact on patients and will FMD help?

Nick Kaye

Nick Kaye, Superintendent, Narrowcliff Pharmacy

• What are quotas and why do we have them?
• How do they impact on patients?
• How they impact on trade?
• FMD’s role in quotas

10:30 Morning Coffee

11:00 Market Access post Brexit

Felipe Florez-Arango

Felipe Florez-Arango, Head of Finance, Europe, Shire

Session reserved for: Felipe A Florez-Arango, Head of Finance, Region Europe, Shire

11:40 Parallel trade – the German perspective on the market

• Drivers of parallel trade with pharmaceuticals in Europe.
Focus: Germany
• Parallel trade and the pressure on the prices of
pharmaceuticals. Quo Vadis parallel trade?
• Latest trends of pharmaceutical parallel trade
 

Shabnam Hanassab

Shabnam Hanassab, Engagement Manager, QuintilesIMS

Frank  Weissenfeldt

Frank Weissenfeldt, Senior Manager, Supplier Relations, QuintilesIMS

12:20 Networking Lunch

13:50 Emerging aspects of parallel trade: Improved access, emergency supplies, social responsibility

Mikas Rimantas

Mikas Rimantas, Business Development Director, Lexano

• Partnering with healthcare authorities for improved patient access to medicines
• Emergency supplies for clinical trials, hospitals and individual patients
• Social responsibility aspects of parallel trade
 

14:30 Status of FMD implementation – Update from Brussels

Heinz Kobelt

Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies

• Readiness of European Medicines Verification System (EMVS) infrastructure, and user preparedness – overview across EEA area
• Connecting manufacturers: experiences gained and learnings for connecting end users: pharmacies and wholesalers
• Integration of parallel distribution sector into the EMVS
• Anti-tampering devices
• Specific cross-border issues: recalls, thefts

15:10 Afternoon Tea

15:40 Patient access to epilepsy drugs in light of pharmaceutical parallel trade

Ian  Walker

Ian Walker , Chairman , Epilepsy Action

• MHRA review: Guidance on patients getting the right version of epilepsy
• The importance of patients receiving the same version of their epilepsy drug
• Issues with generic prescribing and parallel imports
• Differing opinions on consistency of supply

16:20 Key commercial dynamics for parallel trade against the legal and regulatory background

Peter Bogaert

Peter Bogaert, Managing Partner, Covington & Burling

• Commercial drivers in the pharmaceutical parallel trade market
• Branding aspects of parallel imported medicines
• Specific labelling aspects of parallel imports
• Concrete impact of the legal and regulatory principles
• Concrete product examples

17:00 Chair’s Closing Remarks and Close of Day Two

+

FEATURED SPEAKERS

Eric  Noehrenberg

Eric Noehrenberg

President, Noehrenberg International Policy Consulting

Antonio Mendonca Alves

CEO, MD Pharma SA
Antonio Mendonca Alves

Christopher Stothers

Partner, Arnold and Porter Kaye Scholer LLP
Christopher Stothers

Darragh O'loughlin

Secretary General, Irish Pharmacy Union
Darragh O'loughlin

Eric Noehrenberg

President, Noehrenberg International Policy Consulting
Eric  Noehrenberg

Fabrizio Gianfrate

Professor of Health Economics, University of Ferrara
Fabrizio Gianfrate

Farasat Bokhari

Senior Lecturer in Economics, UEA, University of East Anglia
Farasat Bokhari

Felipe Florez-Arango

Head of Finance, Europe, Shire
Felipe Florez-Arango

Frank Weissenfeldt

Senior Manager, Supplier Relations, QuintilesIMS
Frank  Weissenfeldt

Heinz Kobelt

Director European Affairs, European Association of Euro-Pharmaceutical Companies
Heinz Kobelt

Ian Walker

Chairman , Epilepsy Action
Ian  Walker

Iona McCall

Managing Consultant, Europe Economics
Iona McCall

Janice Haigh

VP Pricing & Market Access, PAREXEL
Janice Haigh

John Jolley

Managing Director , PharmaConsult Global Ltd
John Jolley

Mikas Rimantas

Business Development Director, Lexano
Mikas Rimantas

Nick Kaye

Superintendent, Narrowcliff Pharmacy
Nick Kaye

Peter Bogaert

Managing Partner, Covington & Burling
Peter Bogaert

Shabnam Hanassab

Engagement Manager, QuintilesIMS
Shabnam Hanassab

Werner Berg

Partner, Baker & Mckenzie
Werner Berg

VENUE

Holiday Inn Kensington Forum

97 Cromwell Road , London, United Kingdom

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Holiday Inn Kensington Forum

97 Cromwell Road
London SW7 4DN
United Kingdom

Holiday Inn Kensington Forum

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.